Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study

Mette Charlot; Ole Ahlehoff; Mette Lykke Norgaard; Casper H Jørgensen; Rikke Sørensen; Steen Z Abildstrøm; Peter Riis Hansen; Jan Kyst Madsen; Lars Køber; Christian Torp-Pedersen; Gunnar Gislason

doi:10.1059/0003-4819-153-6-201009210-00005

Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study

Mette Charlot, Ole Ahlehoff, Mette Lykke Norgaard, Casper H Jørgensen, Rikke Sørensen, Steen Z Abildstrøm, Peter Riis Hansen, Jan Kyst Madsen, Lars Køber, Christian Torp-Pedersen, Gunnar Gislason

Medicine Glostrup, Department of

243 Citations (Scopus)

Abstract

Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel.

Original language	English
Journal	Annals of Internal Medicine
Volume	153
Issue number	6
Pages (from-to)	378-86
Number of pages	9
ISSN	0003-4819
DOIs	https://doi.org/10.1059/0003-4819-153-6-201009210-00005
Publication status	Published - 21 Sept 2010

Access to Document

10.1059/0003-4819-153-6-201009210-00005

Cite this

Charlot, M., Ahlehoff, O., Norgaard, M. L., Jørgensen, C. H., Sørensen, R., Abildstrøm, S. Z., Hansen, P. R., Madsen, J. K., Køber, L., Torp-Pedersen, C., & Gislason, G. (2010). Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Annals of Internal Medicine, 153(6), 378-86. https://doi.org/10.1059/0003-4819-153-6-201009210-00005

Charlot, M , Ahlehoff, O, Norgaard, ML, Jørgensen, CH, Sørensen, R, Abildstrøm, SZ, Hansen, PR, Madsen, JK, Køber, L , Torp-Pedersen, C & Gislason, G 2010, 'Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study', Annals of Internal Medicine, vol. 153, no. 6, pp. 378-86. https://doi.org/10.1059/0003-4819-153-6-201009210-00005

@article{2ab84a591df94a06a0c9030cd4802ad9,

title = "Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study",

abstract = "Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel.",

author = "Mette Charlot and Ole Ahlehoff and Norgaard, {Mette Lykke} and J{\o}rgensen, {Casper H} and Rikke S{\o}rensen and Abildstr{\o}m, {Steen Z} and Hansen, {Peter Riis} and Madsen, {Jan Kyst} and Lars K{\o}ber and Christian Torp-Pedersen and Gunnar Gislason",

year = "2010",

month = sep,

day = "21",

doi = "10.1059/0003-4819-153-6-201009210-00005",

language = "English",

volume = "153",

pages = "378--86",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "6",

}

TY - JOUR

T1 - Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study

AU - Charlot, Mette

AU - Ahlehoff, Ole

AU - Norgaard, Mette Lykke

AU - Jørgensen, Casper H

AU - Sørensen, Rikke

AU - Abildstrøm, Steen Z

AU - Hansen, Peter Riis

AU - Madsen, Jan Kyst

AU - Køber, Lars

AU - Torp-Pedersen, Christian

AU - Gislason, Gunnar

PY - 2010/9/21

Y1 - 2010/9/21

N2 - Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel.

AB - Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel.

U2 - 10.1059/0003-4819-153-6-201009210-00005

DO - 10.1059/0003-4819-153-6-201009210-00005

M3 - Journal article

C2 - 20855802

SN - 0003-4819

VL - 153

SP - 378

EP - 386

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 6

ER -

Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study

Abstract

Access to Document

Fingerprint

Cite this